BIOCANCELL THERAPEUTICS INC.
company.status.inactiveCIK 1451980fmd_0C1ADYEZ0RZ0PVGJZGAXWB5R94Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 02, 2004 to Mar 31, 2012, 14 periods
Latest annual · FY2011
Millions- Operating income
- (6)
- Net income
- (6)
- Free cash flow
- (5)
Latest quarter · Q1 FY2012
Millions- Operating income
- (1)
- Net income
- (2)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2006 to FY2011
- n/m
BIOCANCELL THERAPEUTICS INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2011 | FY2010 | Change | Source |
|---|---|---|---|---|
| Operating income | -$5.6 million | -$3.8 million | 10-K 2012-03-30 · proof | |
| Net income | -$6 million | -$2.2 million | 10-K 2012-03-30 · proof | |
| Cash from operating activities | -$5.1 million | -$3.1 million | 10-K 2012-03-30 · proof | |
| Free cash flow | -$5.1 million | -$3.1 million | 10-K 2012-03-30 · proof | |
| Total assets | $1.4 million | $6.1 million | -77% | 10-K 2012-03-30 · proof |
| Total liabilities | $4.9 million | $4 million | +22.3% | 10-K 2012-03-30 · proof |
| Cash and cash equivalents | $240,000 | $3.5 million | -93.1% | 10-K 2012-03-30 · proof |
- What was BIOCANCELL THERAPEUTICS INC.'s operating income in fiscal 2011?
- BIOCANCELL THERAPEUTICS INC. reported operating income of -$5.6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$3.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was BIOCANCELL THERAPEUTICS INC.'s net income in fiscal 2011?
- BIOCANCELL THERAPEUTICS INC. reported net income of -$6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was BIOCANCELL THERAPEUTICS INC.'s cash from operating activities in fiscal 2011?
- BIOCANCELL THERAPEUTICS INC. reported cash from operating activities of -$5.1 million for fiscal 2011 (the year ended Dec 31, 2011), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was BIOCANCELL THERAPEUTICS INC.'s free cash flow in fiscal 2011?
- BIOCANCELL THERAPEUTICS INC. reported free cash flow of -$5.1 million for fiscal 2011 (the year ended Dec 31, 2011), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are BIOCANCELL THERAPEUTICS INC.'s total assets?
- As of Dec 31, 2011, BIOCANCELL THERAPEUTICS INC. reported total assets of $1.4 million, against $6.1 million a year earlier (-77%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are BIOCANCELL THERAPEUTICS INC.'s total liabilities?
- As of Dec 31, 2011, BIOCANCELL THERAPEUTICS INC. reported total liabilities of $4.9 million, against $4 million a year earlier (+22.3%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are BIOCANCELL THERAPEUTICS INC.'s cash and cash equivalents?
- As of Dec 31, 2011, BIOCANCELL THERAPEUTICS INC. reported cash and cash equivalents of $240,000, against $3.5 million a year earlier (-93.1%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1451980&period_type=annual&limit=5"Information only, not investment advice.